A Nottingham company behind a product that helps eye heal quicker has raised a further £1.1 million investment.
NuVision said the latest funding round brings the total raised by the company to over £5 million. The business was founded in 2015 by Dr Andy Hopkinson based on his research at the University of Nottingham. Its wound dressings are made using amniotic membrane – the sac that surrounds babies in the womb – and aid the regeneration and healing of the eye’s surface.
Its first product, Omnigen, is already approved for treatment on the NHS and is used in hospitals and private clinics in the UK and overseas. It can be applied in the operating theatre or, when used in combination with the company’s bespoke bandage contact lens, OmniLenz, in the outpatient department or clinic.
